RG
TEVA icon

Redmile Group’s Teva Pharmaceuticals TEVA Stock Holding History

Redmile Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,147,000
Closed -$49.3M – 95
2019
Q1 		$49.3M Buy
3,147,000
+1,318,100
+72% +$23.2M 1.44% 23
2018
Q4 		$28.2M Buy
+1,828,900
New +$37.5M 1.13% 31
2016
Q1 		– Sell
-938,139
Closed -$61.6M – 55
2015
Q4 		$61.6M Sell
938,139
-199,420
-18% -$12.3M 4.75% 8
2015
Q3 		$64.2M Buy
1,137,559
+170,200
+18% +$11M 4.87% 6
2015
Q2 		$57.2M Buy
967,359
+113,386
+13% +$6.99M 4.69% 5
2015
Q1 		$53.2M Buy
+853,973
New +$49.7M 4.78% 5

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return